May 25, 2023 – Astellas Grinds Out A New Target In Stomach And Esophagus Cancer


  • Patients with upper GI cancers are in dire need of new therapeutic options.
  • Astellas is sitting on a shoo-in approval for a brand new targeted therapy based on highly promising clinical trial data.
  • An approval in this space could mean important new revenue inroads for the company.

Read More>